OSCR

Ventricular enlargement is associated with early Alzheimer's disease pathophysiology.

Code ↔ Paper

The paper beside its authors' code: matches between them have not been computed for this paper yet.

Paper

Loaded from Europe PMC by your browser, not stored by OSCR: doi.org · Europe PMC

The paper is loaded when this pane is shown.

The authors' code

Text · 31 lines · 819 B · no license

  1. Welcome to the TNL's tutorial wiki!
  2. This repository includes tutorials and guides in the "Wiki" tab above.
  3. It also contains dictionary files for the following category of TRIAD data:
  4. 1. Neuropsych measures
  5. 2. Fluid biomarkers
  6. Current Wiki pages:
  7. Using Bash
  8. 1. BASH tutorial (Linux and MacOS command prompt)
  9. 2. MincTools 101
  10. 3. Image visualization and mask creation
  11. 4. ASHS segmentation
  12. 5. Distributing tasks to fully use computing power
  13. Software to work from your own computer
  14. 1. X2Go & MobaXTerm
  15. 2. Installing & setting up a MincTools virtual machine on Windows
  16. Statistics skills
  17. 1. Using GGPLOT (R)
  18. 2. Regressions and mediations (R)
  19. 3. RMINC (R)
  20. 4. VoxelStats (MATLAB)
  21. Other guides
  22. 1. Neuropsych battery description
  23. 2. Writing your (first) paper
  24. 3. PET imaging training video
  25. 4. Image quality control on Qrater

readme at commit 0dda6d6, no license · at the source

Overview

Authors: Seyyed Ali Hosseini1,2,3, Etienne Aumont1,2,3, Nesrine Rahmouni1,2,3, Marcel S Woo1,2,4,5, Arthur C Macedo1,2,3, Brandon Hall1,2,3, Lydia Trudel1,2,3, Tevy Chan1,2,3, Jaime Fernandez Arias1,2,3, Yi-Ting Wang1,2,3, Stijn Servaes1,2,3, Joseph Therriault1,2,3, Yansheng Zheng1,2,3, Kely Quispialaya Socualaya1,2,3, Gleb Bezgin1,2,3, Cécile Tissot6, Delphine Oliva-Lopez1,2,3, Robert Hopewell1,3, Chris Hung-Hsin Hsiao2, Catherine Saleh2
and 22 other authorsJenna Stevenson3, Firoza Lussier7, Liyong Wu1, Min Chu1, Sanjeev Chawla8, Vladimir Fonov2, Gassan Massarweh2, Yasser Iturria-Medina2, Jean-Paul Soucy2, David A Rudko2,9, Serge Gauthier2,3, Thomas Karikari7,10,11, Andréa Lessa Benedet10, Nicholas J Ashton10,12,13,14, Henrik Zetterberg10,15,16,17,18,19, Maxime Montembeault3, Paolo Vitali2, Kaj Blennow10,15,20,21, D Louis Collins2, Jesse Klostranec22, Tharick A Pascoal7, Pedro Rosa-Neto1,2,3,23
23 affiliations
  1. Translational Neuroimaging Laboratory, McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, Quebec H3A 2B4, Canada
  2. Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec H3A 1A1, Canada
  3. The McGill University Research Center for Studies in Aging, Douglas Mental Health Institute, Montreal, Quebec H4H 1R3, Canada
  4. Translational Neurodegeneration Laboratory, Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany
  5. Institute of Neuroimmunology and Multiple Sclerosis, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany
  6. Department of Molecular Biophysics and Integrated Bioimaging, Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA
  7. Department of Psychiatry, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15213, USA
  8. Department of Radiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA
  9. Department of Biomedical Engineering, McGill University, Montreal, Quebec H3A 2B4, Canada
  10. Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy, University of Gothenburg, Mölndal 413 45, Sweden
  11. Department of Neurology, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15213, USA
  12. Wallenberg Centre for Molecular Medicine, University of Gothenburg, Gothenburg 413 45, Sweden
  13. King’s College London, Institute of Psychiatry, Department of Psychology and Neuroscience, Maurice Wohl Institute Clinical Neuroscience Institute, London SE5 9NU, UK
  14. NIHR Biomedical Research Centre for Mental Health and Biomedical Research Unit for Dementia at South London and Maudsley NHS Foundation, London, UK
  15. Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal SE-431 80, Sweden
  16. Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK
  17. UK Dementia Research Institute at UCL, London, UK
  18. Hong Kong Center for Neurodegenerative Diseases, Division of Life Science, Hong Kong 999077, China
  19. Wisconsin Alzheimer’s Disease Research Center, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53792, USA
  20. Paris Brain Institute, ICM, Pitié-Salpêtrière Hospital, Sorbonne University, Paris 75013, France
  21. Division of Life Sciences and Medicine, Department of Neurology, Neurodegenerative Disorder Research Center, Institute on Aging and Brain Disorders, University of Science and Technology of China and First Affiliated Hospital of USTC, Hefei 230001, P.R. China
  22. Department of Diagnostic and Interventional Neuroradiology, Montreal Neurological Institute and Hospital, McGill University, Montreal, Quebec H3A 2B4, Canada
  23. The Peter O’Donnell Jr. Brain Institute (OBI), University of Texas Southwestern Medical Centre (UTSW), Dallas, TX 75390, USA
Journal: Brain communications, volume 8, issue 2, article fcag066
Dates: received 29 August 2025; accepted 6 March 2026; published online 7 March 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.1093/braincomms/fcag066 · PMID 41853044 · PMCID PMC12993450 · OpenAlex W7134168166
Open access: gold, a free copy (OpenAlex)
Status: empty repository
Categories: structural MRI / diffusion (modality), PET / SPECT (modality), Alzheimer's / dementia (population), cellular / molecular (subfield)
Methods: Statistics, Preprocessing, Connectivity, fMRI & imaging
Keywords: ventricular enlargement, CSF clearance, choroid plexus, protein aggregation, Alzheimer’s disease
Topic: Cerebrospinal fluid and hydrocephalus (Cellular and Molecular Neuroscience, Neuroscience), according to OpenAlex
Funding: Swedish Alzheimer Foundation (#AF-939721, #ALZ2022-0006, #FO2024-0048-TK-130, #AF-930351, #AF-968270, #ALFGBG-965240, #AF-994551, #ALFGBG-1006418); Canadian Institutes of Health Research (RFN 152985, 33397, 162303, CFI Project 34874, 159815, MOP-11-51-31, NIRG-12-92090, NIRP-12-259245); Swedish Research Council (#2017-00915, #2022-00732); European Union (SG-23-1038904 QC, JPND2019-466-236, ZEN-21-848495); NIA NIH HHS (R01 AG083874); Weston Brain Institute; Corona Foundation; Fonds de Recherche du Québec (2024-VICO-356138, 2020-VICO-279314); Kirsten and Freddy Johansen Foundation (MOP-11-51-31); La Fondation Recherche Alzheimer
Citations: not cited yet (Europe PMC); 67 references in the paper

Abstract

Alzheimer’s disease (AD) is characterized by progressive brain changes, including protein aggregation and structural changes. Cerebrospinal fluid (CSF) system abnormalities, such as ventricular dilation, increased choroid plexus volume or positron emission tomography (PET) ligand uptake in the CSF, have also been consistently described. We aimed to examine whether changes in CSF production and clearance might be associated with brain protein aggregation across biological stages of Alzheimer’s disease. We hypothesized an association between brain protein aggregation and changes on the CSF system. We examined 378 individuals from the Translational Biomarkers in Aging and Dementia (TRIAD) cohort with T1-weighted magnetic resonance imaging (MRI), amyloid-PET and tau-PET assessments. We assessed the lateral ventricle and choroid plexus volumes, both corrected for intracranial volume, in the MRI native space. Non-specific ventricular tracer standardized uptake value ratio (SUVR), derived from amyloid- and tau-PET images, was used as an indirect marker of choroid plexus-related clearance activity and served as a metric of CSF dynamics. Linear models tested associations amongst lateral ventricular volume (reflecting CSF space enlargement), choroid plexus volume (reflecting secretory tissue morphology) and ventricular SUVR (reflecting tracer activity within the CSF compartment and serving as an indirect marker of choroid plexus-related clearance function and CSF dynamics) with Aβ and tau aggregations. Analyses were restricted to within-modality associations, relating ventricular radioactivity to cortical pathology for each PET tracer. We found that when considered independently, larger ventricular and choroid plexus volumes were associated with higher neocortical Aβ-PET SUVR, particularly in the precuneus and cingulate cortices. Additionally, lower ventricular radioactivity (derived from amyloid-PET) showed strong negative associations in the dorsal apex of the neocortex. However, when all three ventricular parameters were included in the same model, these effects were mediated by ventricular volume. By contrast, the effect of the ventricular parameters on tau load was mediated by Aβ in the neocortex. Therefore, ventricular enlargement appears to be associated with Aβ load. Distinct from neurodegeneration, changes in ventricular parameters, particularly ventricular volume, are associated with upstream Alzheimer’s disease pathophysiology. While ventricular volume significantly mediated ventricular amyloid clearance, no such effect was observed for tau, suggesting distinct clearance mechanisms for these pathologies in Alzheimer’s disease.

Reproduced under the paper's license (CC BY), from the paper cited above.

Repository

Its files are read in the Code ↔ Paper reader above.

tnl-mcsa/tutorials

License: none: the authors keep all their rights
State: the link answers, verified on 30 September 2026
Evidence: files inventoried
Commit: 0dda6d6309cbf9980b44aaccb376088c77e8cdca, 18 September 2025
Size: 3 files, 0 scripts
Software Heritage: not archived
Found in: “Data availability”
Holds: README
Not found: license file, CITATION.cff, environment file, tests, continuous integration, documentation
Availability: 1 check, the latest on 30 September 2026: the link answers
  • 30 September 2026: the link answers
1 file

The paper's code and data availability statement is in the Data section.

Tracing map

Proposed by the machine: these links were found in the paper and verified at the source, without human review. The map will receive a Zenodo DOI once one of the paper's authors has validated it with their ORCID.

What the map holds:

  • 1 repository of the authors' code, each at its verified commit, with its license and how the link was found in the paper;
  • 0 scripts, each with its path and the digest of its content;
  • no match between paragraphs and code yet;
  • neither the text of the paper nor the code itself.

Its JSON (tracing-map.json) is deposited on Zenodo with its DOI once the map is validated.

Data

No dataset and no data link were found in the paper.

Data availability

All requests for raw and analysed data and materials will be promptly reviewed by McGill university to verify if the request is subject to any intellectual property or confidentiality obligations. Anonymized data will be shared upon request to the study’s senior author from a qualified academic investigator for the sole purpose of replicating the procedures and results presented in this article. Any data and materials that can be shared will be released via a material transfer agreement. Data are not publicly available due to information that could compromise the privacy of research participants. Related documents, including study protocol and informed consent forms, can similarly be made available upon request. All scripts used for data preprocessing, statistical analyses and figure generation are openly available in our online code repository: https://github.com/TNL-MCSA/Tutorials/wiki.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 30 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 42 authors, 5 keywords, 10 funders, 65 references.

Cite

This paper

Hosseini, S. A., Aumont, E., Rahmouni, N., Woo, M. S., Macedo, A. C., Hall, B., Trudel, L., Chan, T., Fernandez Arias, J., Wang, Y.-T., Servaes, S., Therriault, J., Zheng, Y., Socualaya, K. Q., Bezgin, G., Tissot, C., Oliva-Lopez, D., Hopewell, R., Hsiao, C. H.-H., . . . Rosa-Neto, P. (2026). Ventricular enlargement is associated with early Alzheimer's disease pathophysiology. Brain communications, 8(2), fcag066. https://doi.org/10.1093/braincomms/fcag066

BibTeX

@article{hosseini2026ventricular,
author = {Hosseini, Seyyed Ali and Aumont, Etienne and Rahmouni, Nesrine and Woo, Marcel S and Macedo, Arthur C and Hall, Brandon and Trudel, Lydia and Chan, Tevy and Fernandez Arias, Jaime and Wang, Yi-Ting and Servaes, Stijn and Therriault, Joseph and Zheng, Yansheng and Socualaya, Kely Quispialaya and Bezgin, Gleb and Tissot, Cécile and Oliva-Lopez, Delphine and Hopewell, Robert and Hsiao, Chris Hung-Hsin and Saleh, Catherine and Stevenson, Jenna and Lussier, Firoza and Wu, Liyong and Chu, Min and Chawla, Sanjeev and Fonov, Vladimir and Massarweh, Gassan and Iturria-Medina, Yasser and Soucy, Jean-Paul and Rudko, David A and Gauthier, Serge and Karikari, Thomas and Benedet, Andréa Lessa and Ashton, Nicholas J and Zetterberg, Henrik and Montembeault, Maxime and Vitali, Paolo and Blennow, Kaj and Collins, D Louis and Klostranec, Jesse and Pascoal, Tharick A and Rosa-Neto, Pedro},
title = {{Ventricular enlargement is associated with early Alzheimer's disease pathophysiology}},
journal = {Brain communications},
year = {2026},
month = mar,
volume = {8},
number = {2},
pages = {fcag066},
publisher = {Oxford University Press},
issn = {2632-1297},
doi = {10.1093/braincomms/fcag066},
url = {https://doi.org/10.1093/braincomms/fcag066},
pmid = {41853044},
pmcid = {PMC12993450}
}

RIS

TY - JOUR
AU - Hosseini, Seyyed Ali
AU - Aumont, Etienne
AU - Rahmouni, Nesrine
AU - Woo, Marcel S
AU - Macedo, Arthur C
AU - Hall, Brandon
AU - Trudel, Lydia
AU - Chan, Tevy
AU - Fernandez Arias, Jaime
AU - Wang, Yi-Ting
AU - Servaes, Stijn
AU - Therriault, Joseph
AU - Zheng, Yansheng
AU - Socualaya, Kely Quispialaya
AU - Bezgin, Gleb
AU - Tissot, Cécile
AU - Oliva-Lopez, Delphine
AU - Hopewell, Robert
AU - Hsiao, Chris Hung-Hsin
AU - Saleh, Catherine
AU - Stevenson, Jenna
AU - Lussier, Firoza
AU - Wu, Liyong
AU - Chu, Min
AU - Chawla, Sanjeev
AU - Fonov, Vladimir
AU - Massarweh, Gassan
AU - Iturria-Medina, Yasser
AU - Soucy, Jean-Paul
AU - Rudko, David A
AU - Gauthier, Serge
AU - Karikari, Thomas
AU - Benedet, Andréa Lessa
AU - Ashton, Nicholas J
AU - Zetterberg, Henrik
AU - Montembeault, Maxime
AU - Vitali, Paolo
AU - Blennow, Kaj
AU - Collins, D Louis
AU - Klostranec, Jesse
AU - Pascoal, Tharick A
AU - Rosa-Neto, Pedro
TI - Ventricular enlargement is associated with early Alzheimer's disease pathophysiology
T2 - Brain communications
J2 - Brain Commun
PY - 2026
DA - 2026/03/07
VL - 8
IS - 2
SP - fcag066
SN - 2632-1297
PB - Oxford University Press
DO - 10.1093/braincomms/fcag066
UR - https://doi.org/10.1093/braincomms/fcag066
LA - en
ER -

CSL-JSON

{
"id": "10.1093/braincomms/fcag066",
"type": "article-journal",
"title": "Ventricular enlargement is associated with early Alzheimer's disease pathophysiology",
"container-title": "Brain communications",
"author": [
{
"family": "Hosseini",
"given": "Seyyed Ali"
},
{
"family": "Aumont",
"given": "Etienne"
},
{
"family": "Rahmouni",
"given": "Nesrine"
},
{
"family": "Woo",
"given": "Marcel S"
},
{
"family": "Macedo",
"given": "Arthur C"
},
{
"family": "Hall",
"given": "Brandon"
},
{
"family": "Trudel",
"given": "Lydia"
},
{
"family": "Chan",
"given": "Tevy"
},
{
"family": "Fernandez Arias",
"given": "Jaime"
},
{
"family": "Wang",
"given": "Yi-Ting"
},
{
"family": "Servaes",
"given": "Stijn"
},
{
"family": "Therriault",
"given": "Joseph"
},
{
"family": "Zheng",
"given": "Yansheng"
},
{
"family": "Socualaya",
"given": "Kely Quispialaya"
},
{
"family": "Bezgin",
"given": "Gleb"
},
{
"family": "Tissot",
"given": "Cécile"
},
{
"family": "Oliva-Lopez",
"given": "Delphine"
},
{
"family": "Hopewell",
"given": "Robert"
},
{
"family": "Hsiao",
"given": "Chris Hung-Hsin"
},
{
"family": "Saleh",
"given": "Catherine"
},
{
"family": "Stevenson",
"given": "Jenna"
},
{
"family": "Lussier",
"given": "Firoza"
},
{
"family": "Wu",
"given": "Liyong"
},
{
"family": "Chu",
"given": "Min"
},
{
"family": "Chawla",
"given": "Sanjeev"
},
{
"family": "Fonov",
"given": "Vladimir"
},
{
"family": "Massarweh",
"given": "Gassan"
},
{
"family": "Iturria-Medina",
"given": "Yasser"
},
{
"family": "Soucy",
"given": "Jean-Paul"
},
{
"family": "Rudko",
"given": "David A"
},
{
"family": "Gauthier",
"given": "Serge"
},
{
"family": "Karikari",
"given": "Thomas"
},
{
"family": "Benedet",
"given": "Andréa Lessa"
},
{
"family": "Ashton",
"given": "Nicholas J"
},
{
"family": "Zetterberg",
"given": "Henrik"
},
{
"family": "Montembeault",
"given": "Maxime"
},
{
"family": "Vitali",
"given": "Paolo"
},
{
"family": "Blennow",
"given": "Kaj"
},
{
"family": "Collins",
"given": "D Louis"
},
{
"family": "Klostranec",
"given": "Jesse"
},
{
"family": "Pascoal",
"given": "Tharick A"
},
{
"family": "Rosa-Neto",
"given": "Pedro"
}
],
"container-title-short": "Brain Commun",
"volume": "8",
"issue": "2",
"page": "fcag066",
"DOI": "10.1093/braincomms/fcag066",
"PMID": "41853044",
"PMCID": "PMC12993450",
"ISSN": "2632-1297",
"publisher": "Oxford University Press",
"URL": "https://doi.org/10.1093/braincomms/fcag066",
"language": "en",
"issued": {
"date-parts": [
[
2026,
3,
7
]
]
}
}

The tracing map gets a citation of its own once an author has validated it and it has a DOI.

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1093/brain/awaf375 [code]
Reference proteins to improve Core 1 and Core 2 Alzheimer's disease CSF and plasma biomarkers.
Journal: Brain : a journal of neurology
In common: PET / SPECT, Alzheimer's / dementia, 2 references, 2 authors
[2] doi:10.3390/biology15161423
Circulating Homocysteine and Choroid Plexus Volume Across the Alzheimer's Disease Continuum: Cross-Sectional and Progression-Related Associations.
Journal: Biology
In common: Alzheimer's / dementia, structural MRI / diffusion, 5 references
[3] doi:10.1038/s42003-026-10335-4 [code]
Diurnal choroid plexus function in mice depends on sex, age, and amyloid-β status.
Journal: Communications biology
In common: Alzheimer's / dementia, cellular / molecular, 3 references
[4] doi:10.1093/brain/awaf413 [code]
Estimating the time course of biomarker changes in Alzheimer's disease.
Journal: Brain : a journal of neurology
In common: PET / SPECT, Alzheimer's / dementia, structural MRI / diffusion, 3 references
[5] doi:10.1002/alz.71453
Correlation between in vivo <sup>18</sup>F-flortaucipir PET and whole-brain postmortem histological tau signals in Alzheimer's disease.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
In common: PET / SPECT, Alzheimer's / dementia, 3 references
[6] doi:10.1093/braincomms/fcag129 [code]
Longitudinal changes of choroid plexus volumes and MRI ratios in multiple sclerosis.
Journal: Brain communications
In common: structural MRI / diffusion, 3 references
[7] doi:10.1186/s12880-026-02335-x [code]
Automatic lateral ventricle and choroid plexus segmentation method in infant brain MR images.
Journal: BMC medical imaging
In common: structural MRI / diffusion, 3 references
[8] doi:10.26508/lsa.202603677
The transcriptional cortical response to daily torpor in <i>Phodopus sungorus</i>.
Journal: Life science alliance
In common: cellular / molecular, author Marcel S Woo
[9] doi:10.1093/brain/awaf346
Staging Alzheimer's disease through amyloid and tau PET.
Journal: Brain : a journal of neurology
In common: PET / SPECT, Alzheimer's / dementia, 3 references
[10] doi:10.1038/s42255-026-01527-7
The exercise hormone irisin has neuroprotective effects in a mouse model of multiple sclerosis.
Journal: Nature metabolism
In common: author Marcel S Woo

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.

Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.